Skip to main content

Closed

TARS: Tarsus Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

44thpctl

Volume

0.57×avg

Market Cap

2.54BUSD

P/E Ratio

-51.8TTM

Div Yield

-ann

Tarsus Pharmaceuticals, Inc.

TARSNASDAQ Global Select·USD·Closed

Tarsus Pharmaceuticals, Inc.

TARSNASDAQ·USD·Closed

$59.04

−0.84%

$59.04

−$0.50 (0.84%)

52W Range

44thpctl

Volume

0.57×avg

Mkt Cap

2.54BUSD

P/E

-51.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings